The
global Parry-Romberg syndrome market is majorly driven by the increasing skin
diseases patient population, increasing prevalence neurological disorders, and
rapidly increasing demand for better diagnosis & treatment methods.
Parry-Romberg
Syndrome Market - Highlights
According to the National Organization for Rare
Disorder, Parry-Romberg syndrome is a rare and acquired disorder, which slowly
shrink the skin and tissues of half of the face in most of the cases. In rare
cases, both sides of the face are affected. In some cases, it may also affect
the limbs usually on the same side of the body.
According to the Department of Economic and Social
Affairs Population Division, globally, the number of adults aged over 60 years
were 841 million in 2013, which increased the patient population of eye related
diseases. Taste the market data and market information presented through more
than 125 market data tables and figures spread over 115 pages of the project
report. Avail the in-depth table of content TOC & market synopsis on “Parry
Romberg syndrome market research report–Global forecast till 2023.”
Parry-Romberg
Syndrome Market - Scenario
Parry-Romberg syndrome is also known as progressive hemifacial atrophy. It is a rare disease, which is characterized by the shrinking and degeneration of the tissues beneath the skin. The changes and deterioration spread slowly and it occurs on one side and rarely extends to other parts of the body. On the other hand, high cost of current treatment methods, and long duration for complete cure, for instance, it takes one-two years for facial growth and after facial growth the surgery is proceeded, which may hamper the market growth.
Parry-Romberg syndrome is also known as progressive hemifacial atrophy. It is a rare disease, which is characterized by the shrinking and degeneration of the tissues beneath the skin. The changes and deterioration spread slowly and it occurs on one side and rarely extends to other parts of the body. On the other hand, high cost of current treatment methods, and long duration for complete cure, for instance, it takes one-two years for facial growth and after facial growth the surgery is proceeded, which may hamper the market growth.
The global Parry-Romberg syndrome market is expected to
grow at a CAGR of approximately 7.8% during the forecast period 2017-2023.
Parry-Romberg
Syndrome Market - Key Players
Some of the key players in this market are DePuy
Synthes (U.S.), Johnson & Johnson Services, Inc. (US), Medtronic (Ireland),
Abbott (US), Immediate Media Company Ltd. (US), Taj Pharmaceuticals Ltd.,
Pfizer, Inc., Sanofi-Aventis, Biogen, Inc., GlaxoSmithKline, Inc., and AstraZeneca
plc.
Parry-Romberg
Syndrome Market - Segmentation
The global Parry-Romberg syndrome market is segmented
on the basis of diagnosis, treatment, and end users.
On the basis of diagnosis, the market is segmented into
physical examination, MRI, serum test, and other.
On the basis of treatment, the market is categorized
into drug treatment, surgery, and others. Drug treatment is further segmented
into methotrexate, corticosteroids, cyclophosphamide, and azathioprine, and
other. Surgery segment is sub-segmented into orthognathic surgery,
microsurgical reconstructive surgery, and others.
On the basis of end user, the market is segmented into
hospitals & clinics, physical therapists, and others.
Parry-Romberg Syndrome Market - Intended Audience
Pharmaceutical Companies
Medical Devices
Manufacturer
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors
Parry-Romberg
Syndrome Market - Regional Analysis
The global Parry Romberg syndrome market
consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East
& Africa.
America accounts for the largest Parry-Romberg syndrome
market owing to constantly increasing patient population of skin diseases, eye
diseases, neurological disorder, and increasing government support for
research.
Europe holds the second position in the market due to
increasing development and more focus on healthcare domain. Countries such as
Germany and France are investing more in research & development to develop
new treatment methods for various skin diseases and eye disorder.
Asia Pacific is expected to be the fastest growing
region for Parry-Romberg syndrome market. Increasing geriatric population,
rising healthcare expenditure, and increasing prevalence of skin diseases
drives the growth of the market.
On the other hand, the Middle East & Africa owns
the least share of the Parry-Romberg syndrome market. The Middle East &
Africa is expected witness the least market share due to less development in
healthcare services such as new and advanced diagnosis & treatment methods
in healthcare domain.
Major
Table of Contents for Parry-Romberg Syndrome Market Research Report - Global
Forecast till 2023:
1.
Report Prologue
2.
Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3.
Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4.
Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC
Continued……!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@Marketresearchfuture.com
No comments:
Post a Comment